EBSCO Clinical Decisions Appoints Paul Tuten as Executive Vice President

IPSWICH, Mass. - October 26, 2026 - EBSCO Clinical Decisions today announced the appointment of Paul Tuten as its Executive Vice President. In his role, Tuten will oversee all aspects of EBSCO Clinical Decisions, including strategy, content, product development, and growth. His priorities include advancing the organization's point-of-care strategy and expanding partnerships that bring expert-vetted DynaMed® content directly into the workflows, platforms, and AI-enabled tools clinicians use every day.

"Paul's strong and even-handed leadership is an incredible asset as we work to deliver intelligent, evidence-based tools that elevate care delivery," said Roy Ziegelstein, MD, MACP, Editor-in-Chief and Chief Medical Officer of DynaMed. "His deep technical expertise and track record in academic publishing will help us take the next step in building and delivering trustworthy, evidence-based solutions for clinicians that integrate natively into their daily workflows, reducing friction and improving care when and where it matters most."

Tuten joined the company in 2025 as Executive Vice President and Chief Platform Officer at EBSCO Information Services, focused on accelerating scalable growth of EBSCO's advanced knowledge services. Prior to joining, he was Chief Product and Technology Officer at Taylor & Francis, where he led a global team in driving digital transformation and enhancing data governance, analytics, and platform-centric customer experiences in service to academic researchers. Tuten previously built and repositioned health IT organizations focused on clinical data exchange, patient safety, quality measurement, and revenue cycle management, including at Quantros (now part of RLDatix and Healthcare Bluebook), RxAnte, and ABILITY Network (now part of Inovalon). He holds a PhD in Information Systems from Nova Southeastern University.

"For too long, clinical decision support has worked like a paper map. Useful, but only if you pull over to review it and already know where you are. Clinicians need something closer to GPS, seamlessly integrated into the car and proactively guiding them in real time without having to take their eyes off the road," said Tuten. "At EBSCO Clinical Decisions, our job is to get trusted clinical knowledge everywhere care is delivered. But like GPS, clinical decision support is only as good as the information behind it. With AI tools multiplying and published research outpacing peer review, it's never mattered more that human experts decide what evidence informs it. I'm excited to help bring this vision to life and set a new standard for point-of-care delivery."

Tuten has also advised the federal government on health information exchange and interoperability as a Senior Advisor to the Office of the National Coordinator for Health Information Technology (ONC) at the U.S. Department of Health and Human Services. In that role, he supported the HITECH Act's Meaningful Use program and served as a government liaison to EHR vendors on certification criteria.

To learn more about EBSCO Clinical Decisions, click here.

About EBSCO Clinical Decisions
EBSCO Information Services (EBSCO) helps people find, access, and apply trusted information. Through its EBSCO Clinical Decisions suite of products, EBSCO delivers evidence-based clinical decision-support solutions designed to help healthcare professionals answer clinical questions, support informed decisions, and improve patient care.

EBSCO Clinical Decisions combines trusted clinical content with advanced technologies to support healthcare organizations and clinicians across clinical decision-making, patient care, learning, and research. The suite is designed to provide current, evidence-based information within the clinical workflow, helping healthcare professionals find the answers they need when they need them. For more information, visit www.clinicaldecisions.com. Visit our blog at Health Notes or follow us on X and LinkedIn.

###

For more information, please contact:

Alyssa Horowitz
[email protected]